Pacer Advisors, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$26.42 - $47.12 $1.56 Million - $2.79 Million	59,189 New	59,189 $1.56 Million
Q1 2022 Apr 05, 2022	SELL	$44.58 - $52.6 $1.16 Million - $1.37 Million	-25,979 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$45.82 - $56.9 $1.19 Million - $1.48 Million	25,979 New	25,979 $1.32 Million
Q3 2021 Oct 15, 2021	SELL	$43.79 - $55.78 $1.11 Million - $1.42 Million	-25,434 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$36.86 - $44.5 $471,513 - $569,244	12,792 Added 101.19%	25,434 $1.09 Million
Q1 2021 Apr 05, 2021	BUY	$40.32 - $50.97 $468,760 - $592,577	11,626 Added 1144.29%	12,642 $528,000
Q4 2020 Jan 20, 2021	BUY	$41.72 - $51.34 $5,507 - $6,776	132 Added 14.93%	1,016 $47,000
Q3 2020 Oct 19, 2020	BUY	$37.02 - $51.28 $32,725 - $45,331	884 New	884 $38,000
Q2 2020 Jul 29, 2020	SELL	$43.24 - $55.02 $72,167 - $91,828	-1,669 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$34.37 - $60.07 $138,854 - $242,682	-4,040 Reduced 70.77%	1,669 $87,000
Q4 2019 Feb 10, 2020	SELL	$54.32 - $64.31 $38,512 - $45,595	-709 Reduced 11.05%	5,709 $343,000
Q3 2019 Oct 10, 2019	BUY	$53.25 - $59.98 $53,782 - $60,579	1,010 Added 18.68%	6,418 $363,000
Q2 2019 Aug 12, 2019	BUY	$46.61 - $58.45 $39,944 - $50,091	857 Added 18.83%	5,408 $301,000
Q1 2019 Apr 10, 2019	BUY	$38.66 - $51.82 $175,941 - $235,832	4,551 New	4,551 $230,000
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $87,467 - $161,332	-2,382 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $101,108 - $127,215	1,517 Added 175.38%	2,382 $165,000
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $25,778 - $38,539	503 Added 138.95%	865 $65,000
Q1 2018 May 14, 2018	SELL	$52.16 - $66.86 $56,437 - $72,342	-1,082 Reduced 74.93%	362 $19,000
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $46,971 - $57,643	947 Added 190.54%	1,444 $77,000
Q3 2017 Nov 08, 2017	BUY	$46.62 - $60.36 $23,170 - $29,998	497	497 $30,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account